Compare AbCellera Biologics Inc (ABCL) vs Pinterest Inc (PINS) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AbCellera Biologics Inc vs Pinterest Inc — how do they compare? AbCellera Biologics Inc trades at $7.14 (market cap $2.35B), while Pinterest Inc trades at $22.54 (market cap $12.56B). The key difference: Pinterest Inc is far larger — about 5.3× AbCellera Biologics Inc's market cap, and AbCellera Biologics Inc is trading nearer its 52-week high, Pinterest Inc nearer its low. Which is the better fit depends on your goals.
| ABCL | PINS | |
|---|---|---|
Market Cap | $2.35B | $12.56B |
Sector | Health | Media |
52-Week High | $8.12 | $39.17 |
52-Week Low | $2.78 | $15.42 |
Enterprise Value | $1.99B | $12.47B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AbCellera Biologics (ABCL) trades at $7.69, down 5.18% today, with a bullish technical signal from moving averages but overbought RSI readings. The company reported a net loss of -$146.41M in 2025, with negative margins, though revenue grew to $75.13M. Recent news highlights a major collaboration with Jazz Pharmaceuticals worth up to $876M, potentially boosting future revenue streams. Analyst consensus is strongly bullish with a $9.67 price target, indicating 25.7% upside.
The outlook hinges on execution of new partnerships and pipeline progress, particularly ABCL635 Phase 2 data expected in Q3 2026. Key risks include persistent cash burn, high valuation multiples despite losses, and biotech sector volatility. Investors should weigh the strong analyst support against fundamental challenges and the stock's current technical overbought condition.
Pinterest (PINS) trades at $22.42, up 1.59% with a bullish technical outlook. The company shows strong revenue growth from $2.8B in 2022 to $4.2B in 2025, though net income margin declined to 7.64% in 2026. Recent AI shopping initiatives and Amazon integration highlight strategic moves to boost monetization. Analyst consensus is bullish with a $27.82 price target, representing 24% upside potential from current levels.
PINS presents a growth opportunity with improving fundamentals and strong analyst support, but faces execution risks in monetizing its user base. The stock's elevated P/E ratio of 46.35 requires sustained earnings growth to justify valuation. Competitive pressures in social media and dependency on advertising revenue remain key challenges for long-term investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Pinterest Inc
Pinterest is an online product and idea discovery platform that helps users gather ideas on everything from recipes to cook to destinations to travel to. Founded in 2010, the platform consists of a largely female audience, at roughly two thirds of its more than 365 million monthly active users. The company generates revenue by selling digital ads and is now rolling out more in-platform e-commerce features.
Read more on PINS →
